By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoCellular Therapeutics, Ltd 



Los Angeles  California    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
ImmunoCellular Therapeutics, Ltd (IMUC) Issues Letter To Shareholders, Highlighting Progress On Advancing ICT-107 To Phase 3 Registrational Trial 8/21/2015 6:18:46 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Reaches Agreement With FDA On Special Protocol Assessment (SPA) For ICT-107 Phase 3 Registrational Trial In Glioblastoma 8/13/2015 6:25:04 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Second Quarter 2015 Financial Results 8/7/2015 6:32:47 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Report Second Quarter 2015 Financial Results On August 6, 2015 7/24/2015 10:27:03 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Establishes Agreement With Novella Clinical To Conduct ICT-107 Phase 3 Registration Trial In Glioblastoma 7/6/2015 6:25:35 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Present At Cantor Fitsgerald Inaugural Healthcare Conference On July 8th 6/29/2015 9:29:57 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Establishes Agreement With Pure MHC For Novel Quality Control Assay For ICT-107 Phase 3 Registrational Trial 6/22/2015 6:50:43 AM
PCT, A Caladrius Biosciences Company, Expands Relationship With ImmunoCellular Therapeutics, Ltd (IMUC) To Provide Manufacturing For Their Phase III Trial 6/15/2015 7:51:36 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Enters Into Manufacturing Agreement With PCT LLC, A Caladrius Biosciences Company, For US Production Of ICT-107 For Phase 3 Registration Trial 6/15/2015 6:10:03 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Present At Marcum MicroCap Conference On May 28th 5/19/2015 11:15:09 AM
12345678910...
//-->